iCAD Reports Financial Results for Third Quarter Ended September 30, 2024

NASHUA, N.H., Nov. 13, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three and nine months ended September 30, 2024.  Third Quarter 2024 Highlights (Year over Year Performance): Total ARR was $9.3 million, up 10$4.2 million, up 4% year over yearGro ...